Subscribe
Home Videos Bill Ackman Talks To Congress About Valeant

Bill Ackman Talks To Congress About Valeant

When you purchase through our sponsored links, we may earn a commission. By using this website you agree to our T&Cs.

Published on Apr 27, 2016

April 27 — Bill Ackman, Pershing Square Capital Management’s chief executive officer, speaks at a Senate hearing on Valeant and drug pricing. Pershing Square has investments in Valeant.

SCA_Pearson_4_27_16

SCA_Ackman_4_27_16

SCA_Schiller_4_27_16

More here

Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.

Related news

Is Gray TV Stock a Good Value After It Drops into Penny Stock Territory?
Dave Kovaleski
PepsiCo quarterly earnings fall short of analysts' expectations
PepsiCo: Mixed Q3 Earnings “Subdued”, Execs Say
David Moadel
Vanguard Economist: Can AI Boom Justify High Stock Valuations?
Dave Kovaleski
The Top 4 Value Stocks to Buy Now Amid Correction
Dave Kovaleski
democrats and republicans
The Top 10 Stocks Held by Democrats and Republicans in Congress
Dave Kovaleski

Must Read

New

How to Invest in Stocks in 2024 – Beginner’s Guide

Investing in stocks can be a great way to improve your overall wealth – but...

23 Min Read Read now

Latest News

docusign stock
Business

DocuSign Stock Jumps as CEO Cites “Powerful New Innovation for Customers”
David Moadel3 days

CEO Allan Thygesen hailed the firm's suite of new AI integrations as key revenue drivers Shares of electronic signature technology firm DocuSign (NASDAQ:DOCU) spiked 14% in after-hours trading Thursday as investors weighed...

Categories

Want Financial Guidance Sent Straight to You?

  • Pop your email in the box, and you'll receive bi-weekly emails from ValueWalk.
  • We never send spam — only the latest financial news and guides to help you take charge of your financial future.